UBS Initiates Coverage On Alphatec Holdings with Buy Rating, Announces Price Target of $15
Alphatec Holdings Inc ATEC
$9.52
▼ -1.45%
($-0.14)
📅 Earnings This Week
Open
$9.73
Prev Close
$9.66
Day Range
$9.46 – $9.76
52W Range
$6.82 – $23.29
Market Cap
$1.46B
Beta
0.86
EPS (TTM)
$-0.83
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2006-06-02 |
| Shares Out. | 153,790,000 |
| Website | atecspine.com/ ↗ |
| Phone | 13026365400 |
| Employees | 913 |
| Revenue | $192.1M |
| Gross Profit | $136.5M |
| Net Income | -$33.9M |
| Free Cash Flow | $6.8M |
| Total Assets | $799.5M |
| Total Liabilities | $781.2M |
| Equity | -$5.3M |
About Alphatec Holdings Inc
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.
Alphatec Holdings Inc is a publicly traded company under the ticker symbol ATEC on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
18 analysts (2026-07-01)